To achieve tumor-specific JQ1 delivery and BRD4 inhibition, JQ1 was covalently linked with the hydroxyl group of 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (p-lysoPC) via a thioketal group (Supplementary Figs. 35–38). Here, BRD4 is linked to neoplasm.